Home  >  TopNews
you can get e-magazine links on WhatsApp. Click here
  Delhi HC refuses interim injunction in favour of Sun Pharma in trade mark infringement suit on sitagliptin,   December 01, 2022
  MSF calls on UK-based ViiV Healthcare to dismantle barriers to access for long-acting HIV drug cabotegravir,   December 01, 2022
  Delhi HC issues favourable order to Sun Pharma in Forzest case; imposes Rs. 10 lakh fine for concealing material facts,   November 26, 2022
  Delhi HC warns BDR Pharma to be careful in implementing its orders in future,   November 22, 2022
  Delhi HC settles dispute on territorial jurisdiction of patent appeals post abolition of IPAB,   November 12, 2022
  MSF calls on J&J, Otsuka, TB Alliance to remove barriers blocking generic production of bedaquiline & delamanid,   November 10, 2022
  KKR-backed JB Chemicals receives interim injunction from Delhi High Court on probiotic drug trademark,   November 09, 2022
  Delhi HC consolidates 14 suits and four revocation petitions related to BMS’ apixaban for further hearing,   November 04, 2022
  MSF calls on UK and Indian govts to remove harmful proposals from UK-India FTA negotiation,   November 03, 2022
  SII gets patent for improved process for production of monoclonal antibody for rabies vaccine,   October 13, 2022
  Indian pharma sees pressing need to adopt digital tech to map IP assets and protect its confidentiality,   October 12, 2022
  NIPER, Mohali gets patent for its invention for new anti-TB compound,   October 11, 2022
  Bharat Biotech gets patent for single dose conjugate vaccine Typbar-TCV for typhoid fever,   October 01, 2022
  IPO refuses patent to Mitsubishi for diabetes drug teneligliptin following pre-grant opposition by Glenmark Pharma,   September 12, 2022
  Delhi HC dismisses Sun Pharma’s appeal against Hetero for infringement of its trade mark Letroz,   September 01, 2022
  Delhi HC issues favourable order to Novartis on its divisional patent application for dry eye disease drug,   August 25, 2022
  MSF calls on IPO to make disclosure of INN in patent applications mandatory to reduce its burden,   August 11, 2022
  BMS, Micro Labs to reach amicable settlement as patent for apixaban to end in September 2022,   August 05, 2022
  Patent office refuses BMS’ application for hepatitis C drug,   July 19, 2022
  IPA urges USTR to remove India from Priority Watch List,   July 11, 2022

Apollo Clinical Research
Copyright © 2016 Saffron Media Pvt. Ltd |